Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
137 studies found for:    Open Studies | "Thrombocytopenia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Thrombocytopenia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Protocol for the Infusion of Buffy Coat-derived Cryopreserved Platelets in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Primary Thrombocytopenia,Unspecified;   Thrombocytopenia Chemotherapy Induced
Intervention: Biological: Transfusion of Pooled Platelets Cryopreserved In DMSO
2 Unknown  A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia
Conditions: Alloimmune Thrombocytopenia;   Fetal Alloimmune Thrombocytopenia
Intervention: Drug: IVIG (Intravenous Immunoglobulin)
3 Recruiting Mathematical Modeling to Predict the Duration of Thrombocytopenia in Neonates
Condition: Neonatal Thrombocytopenia
4 Recruiting American Trial Using Tranexamic Acid in Thrombocytopenia
Condition: Thrombocytopenia
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
5 Recruiting Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Other: No intervention
6 Recruiting Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
Condition: Thrombocytopenia
Intervention: Drug: Eltrombopag
7 Recruiting The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study
Condition: Thrombocytopenia
8 Not yet recruiting Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Condition: Neonatal Alloimmune Thrombocytopenia
Intervention: Procedure: Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion
9 Recruiting Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE
Condition: Thrombocytopenia
Interventions: Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
10 Recruiting A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Conditions: CMML;   Thrombocytopenia
Intervention: Drug: eltrombopag
11 Not yet recruiting Prospective Study of Patients With Thrombocytopenia Following HSCT
Conditions: Thrombocytopenia;   Hematologic Diseases
Interventions: Drug: decitabine;   Drug: rhTPO
12 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia,;   Glioblastoma
Intervention: Drug: Romiplostim
13 Recruiting Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Conditions: Hematological Diseases;   Thrombocytopenia
Interventions: Biological: MPs;   Drug: thrombopoietin (TPO) and interleukin-11
14 Not yet recruiting The Effect of Recombinant Human Thrombopoietin on Septic Shock With Thrombocytopenia.
Conditions: Sepsis;   Thrombocytopenia
Interventions: Drug: rhTPO;   Drug: Placebo
15 Unknown  Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
Conditions: Thrombocytopenia;   Hepatitis C;   HIV Infections
Intervention: Drug: Anti-D
16 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Conditions: Antineoplastic Adverse Reaction;   Thrombocytopenia;   Acute Myelocytic Leukemia
Intervention: Drug: rhTPO
17 Recruiting Study of PRTX-100 in Adult Patients With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100
18 Recruiting A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Decitabine
19 Recruiting The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenia
20 Recruiting Open-Label, Dose Escalation Study of PRTX-100 in Adults With Persistent/Chronic Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: PRTX-100

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years